Characteristics | Number | Percentage (%) |
---|---|---|
Sex | ||
Male | 167 | 59.0 |
Female | 116 | 41.0 |
Age groups | ||
15–24 years old | 65 | 23.0 |
25–34 years old | 111 | 39.2 |
35–44 years old | 50 | 17.7 |
45–54 years old | 28 | 9.9 |
> 55 years old | 29 | 10.2 |
WHO clinical stages of HIV | ||
Stage 3 | 120 | 42.4 |
Stage 4 | 163 | 57.6 |
M.tuberculosis/rifampicina (MTB/RIF) | ||
Resistant | 49 | 17.3 |
Not resistant | 234 | 82.7 |
Highly active antirretroviral therapy (HAART) | ||
On HAART | 164 | 58.0 |
Not on HAART | 119 | 42.0 |
Treatment outcome | ||
Died | 158 | 55.8 |
Completed | 125 | 44.2 |